I

IPA

Immunoprecise

1.06

-0.03-2.75%
After Hours: 1.060  0.00  0.00%19:58 07/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

59.99M

77.81M

93.65M

66.96M

27.26M

Total Current Assets

11.49M

16.79M

37.47M

48.86M

7.70M

Total Non Current Assets

48.50M

61.02M

56.18M

18.10M

19.56M

Total Liabilities

26.07M

20.01M

18.36M

10.04M

12.18M

Total Current Liabilities

8.12M

5.92M

9.29M

6.07M

7.93M

Total Non Current Liabilities

17.94M

14.09M

9.07M

3.96M

4.25M

Total Equity

33.92M

57.80M

75.28M

56.92M

15.09M

Total Stockholders Equity

33.92M

57.80M

75.28M

56.92M

15.09M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

59.99M

77.81M

93.65M

66.96M

27.26M

Total Common Shares Outstanding

26.94M

25.05M

24.48M

19.17M

13.98M

Total Preferred Shares Outstanding

--

--

--

--

--